The overall goal of this investigation is to determine the mechanisms of action of IL-1 in brain injury following ischemia or reperfusion. The parameters of brain injury to be monitored include edema, cerebral infarction volume, cerebral blood flow, blood brain barrier permeability, and changes in pathology using methods of immunohistochemistry and enzyme assays. Signs of inflammation to be assessed include the activation of microglial cells and recruitment of neutrophils; in addition, levels of relevant cytokines and adherence molecules are to be monitored. Finally, Adenovirus-IL-1ra constructs are to be used to over-express IL-1ra in the brain to inhibit IL-1-mediated effects in an attempt to establish relationships between IL-1 production and the stimulation of activities that may be responsible for the tissue damage observed in these models of brain injury. Thus, the Specific Aims of the proposal are:
Specific Aim 1 : Identify the mechanism by which IL-1 contributes to brain injury during permanent middle cerebral artery occlusion (pMCAO). Studies performed to satisfy this aim are to include determinations of 1) the time course and location of IL-1 in the ischemic mouse brain, 2) the relationship between the release of IL-1 and other cytokines (e.g., IL-2, IL-6, IL-8, TNFalpha), 3) the role of IL-1 in induction of cell adhesion molecules (e.g., ICAM-1 and CD62E) and infiltration of circulating inflammatory cells (i.e., myeloperoxidase+ neutrophils), and 4) the role of IL-1 in the accumulation and activation of microglial cells.
Specific Aim 2 : Determine whether IL-1 contributes to brain injury during temporary middle cerebral artery occlusion (tMCAO). Studies performed to satisfy this aim are virtually the same as those presented for Aim 1 except the temporary instead of permanent MCAO is to be performed. Therefore, during reperfusion, determinations to be performed are to include 1) the time course for the expression of IL-1beta in mouse brain following tMCAO, 2) whether transient over-expression of IL-1ra produced following intraventricular delivery of the IL-1ra gene carried by adenovirus vectors decreases reperfusion brain injury, and 3) the role of IL-1 in induction of cell adhesion molecules and infiltration of circulating inflammatory cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035089-03
Application #
2858188
Study Section
Special Emphasis Panel (ZRG1-NLS-3 (01))
Program Officer
Jacobs, Tom P
Project Start
1997-01-01
Project End
2000-12-31
Budget Start
1999-01-01
Budget End
2000-12-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Surgery
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Wang, Zhi-Qiu; Wu, Du-Chu; Huang, Feng-Ping et al. (2004) Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 996:55-66
Huang, Feng-Peng; Wang, Zhi-Qiu; Wu, Du-Chu et al. (2003) Early NFkappaB activation is inhibited during focal cerebral ischemia in interleukin-1beta-converting enzyme deficient mice. J Neurosci Res 73:698-707
Zhu, Yuan; Yang, Guo-Yuan; Ahlemeyer, Barbara et al. (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22:3898-909
Pang, L; Ye, W; Che, X M et al. (2001) Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 32:544-52
Masada, T; Hua, Y; Xi, G et al. (2001) Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J Neurosurg 95:680-6
Che, X; Ye, W; Panga, L et al. (2001) Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 902:171-7
Yang, G Y; Pang, L; Ge, H L et al. (2001) Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J Cereb Blood Flow Metab 21:722-33
Mao, Y; Yang, G; Zhou, L (2000) Temporary and permanent focal cerebral ischemia in the mouse: assessment of cerebral blood flow, brain damage and blood-brain barrier permeability. Chin Med J (Engl) 113:361-6
Wu, D C; Ye, W; Che, X M et al. (2000) Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J Cereb Blood Flow Metab 20:1320-30
Yang, G Y; Mao, Y; Zhou, L F et al. (1999) Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist. Brain Res Mol Brain Res 72:129-37

Showing the most recent 10 out of 19 publications